All lobbying filings
UPSTREAM CONSULTING
Lobbying for PRIMUS PHARMACEUTICAL · Pharmaceutical drug manufacturing
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Nov 3, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Virginia
Representation ended
Jul 1, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.